2020 Molecular Rapid Aneuploidy (MRA)

Scheme description
Prenatal DNA samples for rapid aneuploidy testing for the chromosomes 13, 18, 21, X and Y, and triploidy using QF-PCR.
Disorders/Gene target(s)
Common aneuploidies in prenatal clinical cases
Trisomy 13
Trisomy 18
Trisomy 21
Triploidy
Turner syndrome
Klinefelter syndrome
Clinical cases
Three
Testing/analysis
Detection of common aneuploidies
Sample type
DNA in TE buffer
Techniques
QF-PCR
Assessment
Submit a clinical report to include:
● Analysis of results
● Interpretation of the result
● Clerical accuracy
Performance criteria are applied.
Interpretation and Clerical Accuracy
Eligibility
All laboratories worldwide
Languages
English, French, German, Italian, Spanish.
ISO17043 Accredited EQA
Yes
EQA timeline
Sample dispatchSeptember 2020
Testing period5 weeks
Assessment resultsDecember 2020
Final Summary reportFebruary 2021
Other information
Fee
£375.00
GenQA code
2020MRA
« Return to EQA scheme list
Go to top